Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff
PharmExec
JANUARY 11, 2023
Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for. As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments.
110 
Let's personalize your content